These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38360354)

  • 1. GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells.
    Shilleh AH; Viloria K; Broichhagen J; Campbell JE; Hodson DJ
    Peptides; 2024 May; 175():171179. PubMed ID: 38360354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus.
    Smith C; Patterson-Cross R; Woodward O; Lewis J; Chiarugi D; Merkle F; Gribble F; Reimann F; Adriaenssens A
    Appetite; 2022 Jul; 174():106022. PubMed ID: 35430298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
    Maida A; Lamont BJ; Cao X; Drucker DJ
    Diabetologia; 2011 Feb; 54(2):339-49. PubMed ID: 20972533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
    Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reagents and models for detecting endogenous GLP1R and GIPR.
    Ast J; Broichhagen J; Hodson DJ
    EBioMedicine; 2021 Dec; 74():103739. PubMed ID: 34911028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
    Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
    J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
    van Eenige R; Ying Z; Tramper N; Wiebing V; Siraj Z; de Boer JF; Lambooij JM; Guigas B; Qu H; Coskun T; Boon MR; Rensen PCN; Kooijman S
    Atherosclerosis; 2023 May; 372():19-31. PubMed ID: 37015151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.
    Moon MJ; Kim HY; Kim SG; Park J; Choi DS; Hwang JI; Seong JY
    Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
    Yuliantie E; Darbalaei S; Dai A; Zhao P; Yang D; Sexton PM; Wang MW; Wootten D
    Biochem Pharmacol; 2020 Jul; 177():114001. PubMed ID: 32360365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice.
    Croze ML; Flisher MF; Guillaume A; Tremblay C; Noguchi GM; Granziera S; Vivot K; Castillo VC; Campbell SA; Ghislain J; Huising MO; Poitout V
    Mol Metab; 2021 Mar; 45():101166. PubMed ID: 33484949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation.
    Mayendraraj A; Rosenkilde MM; Gasbjerg LS
    Peptides; 2022 May; 151():170749. PubMed ID: 35065096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of GIP in α-cells and glucagon secretion.
    El K; Campbell JE
    Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells.
    Manchanda Y; Bitsi S; Chen S; Broichhagen J; Bernardino de la Serna J; Jones B; Tomas A
    Endocrinology; 2023 Mar; 164(5):. PubMed ID: 36774542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
    Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E
    Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells.
    Gray SM; Xin Y; Ross EC; Chazotte BM; Capozzi ME; El K; Svendsen B; Ravn P; Sloop KW; Tong J; Gromada J; Campbell JE; D'Alessio DA
    J Biol Chem; 2020 Aug; 295(33):11529-11541. PubMed ID: 32554468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes.
    Kizilkaya HS; Sørensen KV; Madsen JS; Lindquist P; Douros JD; Bork-Jensen J; Berghella A; Gerlach PA; Gasbjerg LS; Mokrosiński J; Mowery SA; Knerr PJ; Finan B; Campbell JE; D'Alessio DA; Perez-Tilve D; Faas F; Mathiasen S; Rungby J; Sørensen HT; Vaag A; Nielsen JS; Holm JC; Lauenborg J; Damm P; Pedersen O; Linneberg A; Hartmann B; Holst JJ; Hansen T; Wright SC; Lauschke VM; Grarup N; Hauser AS; Rosenkilde MM
    Nat Metab; 2024 Jul; 6(7):1268-1281. PubMed ID: 38871982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
    Akindehin S; Liskiewicz A; Liskiewicz D; Bernecker M; Garcia-Caceres C; Drucker DJ; Finan B; Grandl G; Gutgesell R; Hofmann SM; Khalil A; Liu X; Cota P; Bakhti M; Czarnecki O; Bastidas-Ponce A; Lickert H; Kang L; Maity G; Novikoff A; Parlee S; Pathak E; Schriever SC; Sterr M; Ussar S; Zhang Q; DiMarchi R; Tschöp MH; Pfluger PT; Douros JD; Müller TD
    Mol Metab; 2024 May; 83():101915. PubMed ID: 38492844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of signal transduction mediated by the human GIPR splice variants.
    Zhao F; Hang K; Zhou Q; Shao L; Li H; Li W; Lin S; Dai A; Cai X; Liu Y; Xu Y; Feng W; Yang D; Wang MW
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2306145120. PubMed ID: 37792509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells.
    Al-Zaid B; Chacko S; Ezeamuzie CI; Bünemann M; Krasel C; Karimian T; Lanzerstorfer P; Al-Sabah S
    Pharmacol Res Perspect; 2022 Oct; 10(5):e01013. PubMed ID: 36177761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glucagon-like peptide-1 receptor and glucose‑dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells.
    Aoyama E; Watari I; Podyma-Inoue KA; Yanagishita M; Ono T
    Int J Mol Med; 2014 Aug; 34(2):475-82. PubMed ID: 24866833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.